Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20
How Much Larger Is The Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market Expected To Become By 2029 Compared With Its 2025 Level?
The investigational new drug contract development and manufacturing organization (CDMO) market has experienced substantial growth in recent years. It is anticipated to expand from $5.53 billion in 2024 to $5.91 billion in 2025, reflecting a compound annual growth rate (CAGR) of 7.0%. This historical growth can be attributed to factors such as increasing demand for early-phase clinical trials, greater outsourcing by pharmaceutical companies, an increase in the development of biologics and complex molecules, growing regulatory support for accelerated drug approvals, and a heightened focus on cost-efficiency and speed-to-market.
The investigational new drug contract development and manufacturing organization (CDMO) market is projected to experience robust expansion over the coming years. This market is set to reach $7.67 billion by 2029, exhibiting a compound annual growth rate (CAGR) of 6.7%. Key factors driving this growth during the forecast period include a heightened focus on the development of rare and orphan drugs, a greater demand for integrated preclinical-to-clinical services, the increasing intricacy of biologics and gene therapies, rising investment in small molecule innovation, and the growing adoption of virtual pharmaceutical business models. Significant trends anticipated in the forecast period involve progress in integrated drug development platforms, the emergence of AI-driven clinical trial designs, innovations in personalized medicine manufacturing, improvements in regulatory compliance technologies, and the establishment of flexible and modular manufacturing facilities.
Unlock Your Free Sample Report for Exclusive Market Data:
https://www.thebusinessresearchcompany.com/sample.aspx?id=25803&type=smp
Which Industry Drivers Are Expected To Accelerate The Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market From 2025 To 2029?
The expansion of clinical trials is projected to fuel the growth of the investigational new drug contract development and manufacturing organization (CDMO) market in the coming years. These trials are meticulously structured research endeavors that involve human participants, designed to evaluate the safety and efficacy of medical interventions, treatments, or procedures within controlled settings. The uptick in clinical trials primarily stems from an increasing need for novel therapies, as the rising prevalence of chronic and intricate diseases encourages pharmaceutical and biotechnology firms to develop and assess new treatments. Investigational new drug CDMOs play a crucial role in supporting clinical trials by optimizing the development and production of drug formulations suitable for trials, thereby guaranteeing a prompt and compliant provision of investigational products for every stage of a study. For example, in November 2023, the Association of the British Pharmaceutical Industry, a UK-based trade body, reported that the UK experienced a 4.3% increase in the annual number of industry-led clinical trials, climbing from 394 in 2021 to 411 in 2022. Consequently, the increasing volume of clinical trials is a key factor propelling the expansion of the investigational new drug contract development and manufacturing organization (CDMO) market.
Which Key Segments Fueling The Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market?
The investigational new drug contract development and manufacturing organization (cdmo) market covered in this report is segmented –
1) By Product: Small Molecules, Large Molecules
2) By Formulation Type: Solid Formulations, Liquid Formulations, Injectable Formulations
3) By Service Type: Clinical Trial Material Supply, Regulatory Support Services, Manufacturing Services
4) By End-User: Biotechnology Companies, Academic And Research Institutes, Other End-Users
Subsegments:
1) By Small Molecules: Synthetic Small Molecules, Semi-synthetic Small Molecules, Peptide-based Small Molecules, Oligonucleotides
2) By Large Molecules: Monoclonal Antibodies (mAbs), Recombinant Proteins, Vaccines, Cell Therapy Products, Gene Therapy Products, RNA-based Therapeutics
Which Trends Are Impacting The Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market?
Leading firms within the investigational new drug contract development and manufacturing organization (CDMO) market are prioritizing strategic alliances to enhance their development proficiencies and accelerate their progression into clinical stages. Such partnerships represent formal collaborations among multiple organizations, designed to pursue common goals by utilizing their collective strengths, assets, or specialized knowledge for reciprocal advantages, all while maintaining their individual autonomy. A notable illustration occurred in August 2023, when Sartorius AG, a life science company headquartered in Germany, collaborated with Repligen Corporation, a US-based life sciences firm, to introduce an integrated system that merges BIOSTAT STR and XCell ATF technologies for optimizing upstream processes. The objective of this joint effort is to streamline biopharmaceutical manufacturing through improvements in both efficiency and scalability. This endeavor underscores Sartorius’ ongoing commitment to innovation in bioprocessing solutions, further solidifying its dedication to progressing the biomanufacturing sector.
Which Key Players Are Driving Competition In The Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market?
Major companies operating in the investigational new drug contract development and manufacturing organization (cdmo) market are Thermo Fisher Scientific Inc., Fresenius Kabi AG, Lonza Group Ltd., Catalent Inc., Samsung Biologics Co. Ltd., Fareva SA, Recipharm AB, PCI Pharma Services, Vetter Pharma, Delpharm, Kindeva Drug Delivery LP, Ajinomoto Bio-Pharma Services, Cenexi SAS, Grand River Aseptic Manufacturing Inc., INCOG BioPharma Services, Aurigene Pharmaceutical Services, Jubilant HollisterStier LLC, Symbiosis Pharmaceutical Services Ltd., Afton Scientific Corp., Amaran Biotech Inc.
Download The Full Report For Exclusive Market Findings:
What Are The Regional Market Dynamics Impacting The Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Industry?
North America was the largest region in the investigational new drug contract development and manufacturing organization (CDMO) market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the investigational new drug contract development and manufacturing organization (cdmo) market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Customized Version Of The Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market Report:
https://www.thebusinessresearchcompany.com/customise?id=25803&type=smp
Browse Through More Reports Similar to the Global Investigational New Drug Contract Development And Manufacturing Organization (CDMO) Market 2025, By The Business Research Company
Pharmaceutical Contract Developments And Manufacturing Organization Cmo Global Market Report 2025
Topical Drugs Contract Development And Manufacturing Organization Cdmo Global Market Report 2025
Advanced Therapy Medicinal Products Contract Development And Manufacturing Organization Cdmo Global Market Report 2025
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model